Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Medicine, Gynecology, Oncology +16

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.

Kazumitsu Ueda, Carol Cardarelli, Michael M. Gottesman et al. · Proceedings of the National Academy of Sciences · 1987 · 1.1K citations · Full text

Medicine, Molecular Biology, Oncology +11

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

Maurie Markman, Robert Rothman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 854 citations

Medicine, Gynecology, Oncology +13

The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer

M. van Lent, Marc Buyse, A Kobierska et al. · New England Journal of Medicine · 1995 · 720 citations · Full text

Medicine, Oncology, Surgery +11